State-specific protein-ligand complex structure prediction with a multi-scale deep generative model

TL;DR

NeuralPLexer is a deep generative model that accurately predicts protein-ligand complex structures and conformational changes from sequences and molecular graphs, surpassing existing methods and aiding drug discovery.

Contribution

The paper introduces NeuralPLexer, a novel multi-scale deep generative model that predicts 3D protein-ligand structures and conformational ensembles directly from sequences and graphs.

Findings

Achieves state-of-the-art performance on binding complex benchmarks.

Outperforms AlphaFold2 in structure accuracy for conformationally flexible proteins.

Successfully predicts conformational variations consistent with experimental data.

Abstract

The binding complexes formed by proteins and small molecule ligands are ubiquitous and critical to life. Despite recent advancements in protein structure prediction, existing algorithms are so far unable to systematically predict the binding ligand structures along with their regulatory effects on protein folding. To address this discrepancy, we present NeuralPLexer, a computational approach that can directly predict protein-ligand complex structures solely using protein sequence and ligand molecular graph inputs. NeuralPLexer adopts a deep generative model to sample the 3D structures of the binding complex and their conformational changes at an atomistic resolution. The model is based on a diffusion process that incorporates essential biophysical constraints and a multi-scale geometric deep learning system to iteratively sample residue-level contact maps and all heavy-atom coordinates in a hierarchical manner. NeuralPLexer achieves state-of-the-art performance compared to all existing methods on benchmarks for both protein-ligand blind docking and flexible binding site structure recovery. Moreover, owing to its specificity in sampling both ligand-free-state and ligand-bound-state ensembles, NeuralPLexer consistently outperforms AlphaFold2 in terms of global protein structure accuracy on both representative structure pairs with large conformational changes (average TM-score=0.93) and recently determined ligand-binding proteins (average TM-score=0.89). Case studies reveal that the predicted conformational variations are consistent with structure determination experiments for important targets, including human KRAS$^\textrm{G12C}$, ketol-acid reductoisomerase, and purine GPCRs. Our study suggests that a data-driven approach can capture the structural cooperativity between proteins and small molecules, showing promise in accelerating the design of enzymes, drug molecules, and beyond.